Antivascular ultrasound therapy extends survival of mice with implanted melanomas.
The goal of this murine investigation was to evaluate the effect of an antivascular ultrasound treatment on the growth of an implanted melanoma and the consequent survival rate. After the intravenous injection of 0.2 mL ultrasound contrast agent (Definity), therapy (n = 15) was performed on 1-mL tumors for 3 min with low-intensity continuous ultrasound (3 MHz; 2.4 +/- 0.1 W cm(-2) [I(SATA)]); control mice (n = 17) received a sham treatment. Mice were euthanized once the tumor had reached 3 mL, and then survival percentage vs. time curves were plotted. The median survival time (time for tumor to reach 3 mL) for the treated group was 23 d and for the control group was 18 d; the difference was statistically significant (p <or= 0.0001). Antivascular ultrasound therapy reduced the growth rate of an implanted melanoma and increased survival time. The ultrasound therapy provides a further example of tumor vascular disruption, and its future clinical potential should be investigated.
Wood
Andrew K W
AK
Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Schultz
Susan M
SM
Lee
William M-F
WM
Bunte
Ralph M
RM
Sehgal
Chandra M
CM
D000818:Animals; D045744:Cell Line, Tumor; D008545:Melanoma / Q000473:pathology* / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D009389:Neovascularization, Pathologic / Q000473:pathology* / Q000628:therapy*; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome; D014464:Ultrasonic Therapy / Q000379:methods*
Eur Urol. 1993;23 Suppl 1:34-8
8513832
Clin Cancer Res. 2006 May 1;12(9):2834-40
16675578
Acta Biomed. 2008 Dec;79(3):211-6
19260381
J Clin Oncol. 2006 Apr 1;24(10):1491-8
16574998
Br J Cancer. 1982 Jan;45(1):136-9
7059456
Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1491-6
12459376
Ultrasound Med Biol. 2006 Mar;32(3):453-61
16530105
Acad Radiol. 2009 Jan;16(1):71-8
19064214
Ultrasound Med Biol. 2007 Dec;33(12):1901-10
17720299
Eur J Cancer Clin Oncol. 1983 Feb;19(2):271-5
6681772
Acad Radiol. 2008 Sep;15(9):1133-41
18692754
Cancer Chemother Pharmacol. 1989;24(1):15-22
2597279
Ultrasound Med Biol. 2005 Oct;31(10):1403-10
16223644
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):859-66
18164835
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):211-7
17448875
J Clin Oncol. 2003 Aug 1;21(15):2815-22
12807934
Br J Radiol. 2008 Oct;81 Spec No 1:S12-20
18819993
Adv Urol. 2008;:809845
19132094
Br J Cancer. 2003 Apr 22;88(8):1160-7
12698178
Lancet Oncol. 2003 Mar;4(3):141-8
12623359
Br J Cancer. 2007 Apr 23;96(8):1159-65
17375046
J Clin Pathol. 2000 May;53(5):391-4
10889823
Bioorg Med Chem. 2007 Jan 15;15(2):605-15
17070061